Gradalis®, Inc. is a fully integrated biotechnology company based in Dallas, Texas that focuses on the development, manufacturing, and commercialization of drugs, immunotherapies, tools, and diagnostics primarily in the area of cancer. Gradalis® has its own GMP manufacturing facility along with highly skilled technical leadership and staff and a strategic partnership with Mary Crowley Cancer Research Centers for clinical development of Gradalis® products.

Research Grants 8 show all


$99.5K
2008

$499.9K
2009

$199K
2010

$50K
2011

$150K
2012

Publications 13 show all

  • 4
    RNA Interference
  • 3
    RNA, Small Interfering/genetics
  • 2
    Gene Knockdown Techniques/methods
  • 2
    Genetic Therapy/methods
  • 2
    Homeodomain Proteins/genetics
  • 2
    Neoplasms/therapy
  • 2
    RNA, Small Interfering/metabolism
  • 2
    Stathmin/metabolism
  • 2
    Trans-Activators/genetics
  • 1
    Adenocarcinoma/genetics

Patents 416show all

  • 191
    G11C - Static stores
  • 130
    H01L - Semiconductor devices
  • 104
    C12N - Microorganisms or enzymes
  • 93
    B82Y - Specific uses or applications of nanostructures
  • 82
    A61K - Preparations for medical, dental, or toilet purposes
  • 78
    H01F - Magnets
  • 34
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 25
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 20
    G01R - Measuring electric variables
  • 19
    C07H - Sugars

Clinical Trials 16show all

10Phase 24Phase 11Phase 3

SEC Filings show all


2
D

Contact Information

Dallas, TX
United States

SEC Form D Funding Events

DateOfferedSoldType
2009-02-26Unknown Unknown Other (Paper Filing)